BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11642203)

  • 21. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diabetes mellitus, hypertension and kidney].
    Monhart V
    Vnitr Lek; 2008 May; 54(5):499-504, 507. PubMed ID: 18630636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of serum cystatin C in Japanese patients with type 2 diabetes mellitus and nephropathy.
    Kimura T; Ikeda H; Fujikawa J; Nomura K; Aoyama T; Wada Y; Nabe K; Hamamoto Y; Honjo S; Koshiyama H
    Diabetes Res Clin Pract; 2009 Feb; 83(2):e58-61. PubMed ID: 19118914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dyslipidemia and cardiovascular risk in type 2 diabetes mellitus patients with associated diabetic nephropathy].
    Martínez-Castelao A; Ramos R; González MT; Castiñeiras MJ
    Nefrologia; 2002; 22 Suppl 1():51-8. PubMed ID: 11987671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetic nephropathy: implications for renal and cardiovascular outcomes.
    Folan LA; Tuttle KR
    Minerva Med; 2004 Oct; 95(5):385-94. PubMed ID: 15467514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of TGF-beta in pathogenesis of diabetic nephropathy.
    Pantsulaia T
    Georgian Med News; 2006 Feb; (131):13-8. PubMed ID: 16575121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal renal structural alterations during the development of diabetes mellitus in Otsuka Long-Evans Tokushima Fatty rats.
    Koike T; Tomoda F; Kinuno H; Inoue H; Takata M
    Acta Physiol Scand; 2005 May; 184(1):73-81. PubMed ID: 15847646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Model's short life and murine resistance, another ''no'' revolution].
    Cornacchia F
    G Ital Nefrol; 2007; 24(4):282. PubMed ID: 17659494
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevalence of atubular glomeruli in type 2 diabetic patients with nephropathy.
    White KE; Marshall SM; Bilous RW
    Nephrol Dial Transplant; 2008 Nov; 23(11):3539-45. PubMed ID: 18558622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evaluation of renal biopsy in type-II diabetic patients.
    Arif M; Arif MK; Arif MS
    J Coll Physicians Surg Pak; 2009 Oct; 19(10):627-31. PubMed ID: 19811713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production.
    Prabhakar S; Starnes J; Shi S; Lonis B; Tran R
    J Am Soc Nephrol; 2007 Nov; 18(11):2945-52. PubMed ID: 17928507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Glomerular hyperfiltration in diabetic nephropathy].
    Ito O; Ito S
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():331-5. PubMed ID: 15999729
    [No Abstract]   [Full Text] [Related]  

  • 33. Renal affection in patients with diabetes mellitus is not always caused by diabetic nephropathy.
    Zukowska-Szczechowska E; Tomaszewski M
    Rocz Akad Med Bialymst; 2004; 49():185-9. PubMed ID: 15631340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
    Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Progress in diagnosis and treatment of renal diseases. II. Nephropathies associated with systemic diseases. Diabetic nephropathy with NIDDM].
    Yajima Y
    Nihon Naika Gakkai Zasshi; 1996 Oct; 85(10):1650-6. PubMed ID: 8999056
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of mesangial expansion in the pathogenesis of diabetic nephropathy.
    Dalla Vestra M; Saller A; Mauer M; Fioretto P
    J Nephrol; 2001; 14 Suppl 4():S51-7. PubMed ID: 11798146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood glucose and lipid control as risk factors in the progression of renal damage in type 2 diabetes.
    Nosadini R; Tonolo G
    J Nephrol; 2003; 16 Suppl 7():S42-7. PubMed ID: 14733300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiology of diabetic nephropathy.
    Sego S
    Nephrol Nurs J; 2007; 34(6):631-3. PubMed ID: 18203571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glomerular filtration rate changes in normoalbuminuric and microalbuminuric Type 2 diabetic patients and normal individuals A 10-year follow-up.
    Murussi M; Gross JL; Silveiro SP
    J Diabetes Complications; 2006; 20(4):210-5. PubMed ID: 16798471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional erythropoietin deficiency in patients with Type 2 diabetes and anaemia.
    Thomas MC; Tsalamandris C; Macisaac R; Jerums G
    Diabet Med; 2006 May; 23(5):502-9. PubMed ID: 16681558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.